Project Ronin delivers a Cancer Intelligence Platform as a service to oncology providers (hospitals, cancer centers, and clinics). The platform combines a patient-facing app for symptom tracking and communication with a clinician-facing dashboard that aggregates health data, including treatment history, lab results, and genomic information. It uses data analytics to generate personalized insights and treatment recommendations to help oncologists make better-informed decisions and to improve the patient care experience. The subscription-based model targets the oncology market from small community practices to large academic centers. Unlike generic health IT tools, the platform is purpose-built for cancer care, integrating patient engagement with clinical decision support in a single system. The goal is to improve cancer outcomes and patient experience by enabling data-driven, timely clinical interventions and better coordination between patients and their care teams.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Seed
Total Funding
$35M
Headquarters
San Mateo, California
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$35M
Above
Industry Average
Funded Over
0 Rounds
SAN FRANCISCO, July 11, 2023 /PRNewswire/ — Ronin, an innovator of evidence-based clinical decision support, today announced that its Chief Scientific Officer (CSO), Christine Swisher, Ph.D., has joined the Coalition for Health AI (CHAI) as an advisor.
Find jobs on Simplify and start your career today
Industries
Company Size
51-200
Company Stage
Seed
Total Funding
$35M
Headquarters
San Mateo, California
Founded
2018
Find jobs on Simplify and start your career today